Correlation Between NYSE Composite and Aligos Therapeutics
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Aligos Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Aligos Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Aligos Therapeutics, you can compare the effects of market volatilities on NYSE Composite and Aligos Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Aligos Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Aligos Therapeutics.
Diversification Opportunities for NYSE Composite and Aligos Therapeutics
0.27 | Correlation Coefficient |
Modest diversification
The 3 months correlation between NYSE and Aligos is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Aligos Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aligos Therapeutics and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Aligos Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aligos Therapeutics has no effect on the direction of NYSE Composite i.e., NYSE Composite and Aligos Therapeutics go up and down completely randomly.
Pair Corralation between NYSE Composite and Aligos Therapeutics
Assuming the 90 days trading horizon NYSE Composite is expected to generate 21.11 times less return on investment than Aligos Therapeutics. But when comparing it to its historical volatility, NYSE Composite is 17.03 times less risky than Aligos Therapeutics. It trades about 0.41 of its potential returns per unit of risk. Aligos Therapeutics is currently generating about 0.51 of returns per unit of risk over similar time horizon. If you would invest 955.00 in Aligos Therapeutics on September 2, 2024 and sell it today you would earn a total of 1,596 from holding Aligos Therapeutics or generate 167.12% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
NYSE Composite vs. Aligos Therapeutics
Performance |
| Timeline |
NYSE Composite and Aligos Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Aligos Therapeutics
Pair trading matchups for Aligos Therapeutics
Pair Trading with NYSE Composite and Aligos Therapeutics
The main advantage of trading using opposite NYSE Composite and Aligos Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Aligos Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aligos Therapeutics will offset losses from the drop in Aligos Therapeutics' long position.| NYSE Composite vs. Simon Property Group | NYSE Composite vs. Merit Medical Systems | NYSE Composite vs. Catalent | NYSE Composite vs. Titan Machinery |
| Aligos Therapeutics vs. Tff Pharmaceuticals | Aligos Therapeutics vs. Eliem Therapeutics | Aligos Therapeutics vs. Inhibrx | Aligos Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |